Abstract
Along with other lactic acid bacteria, enterococci are used in food products and as health promoting agents. The safety of these products must be ensured, because they contain potentially pathogenic microorganisms. Here we present an in vitro opsonophagocytic assay that closely mimics the protective human immune response to Enterococcus faecalis and Enterococcus faecium. A collection of closely related E. faecalis isolates used as probiotics showed different susceptibilities to opsonic killing, suggesting that some of these isolates possess a capsule while other do not. This information may be helpful in assessing the safety of a given bacterial isolate used and could detect likely enterococcal candidates for probiotic preparations.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is dedicated to the founders of the Walter Marget Foundation, D. Adam and F. Daschner, in gratitude for their support of the training in infectious diseases.
Rights and permissions
About this article
Cite this article
Kropec, A., Hufnagel, M., Zimmermann, K. et al. In vitro Assessment of the Host Response against Enterococcus faecalis Used in Probiotic Preparations. Infection 33, 377–379 (2005). https://doi.org/10.1007/s15010-005-5063-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s15010-005-5063-7